Publications by authors named "Berit Pfitzner"

Claim this Profile
T
The landscape of genetic aberrations in myxofibrosarcoma.
Yasuhide Takeuchi, Kenichi Yoshida, Adriane Halik, Annegret Kunitz, Hiromichi Suzuki, Berit Maria Pfitzner

Int J Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict).
Paul Jank, Judith Lea Lindner, Annika Lehmann, Berit Maria Pfitzner, Jens-Uwe Blohmer

Breast Cancer Res Treat· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two case reports: Breast schwannoma and a rare case of an axillary schwannoma imitating an axillary lymph node metastasis.
Martin Duehrkoop, Bernd Frericks, Christine Ankel, Christine Boettcher, Wolfgang Hartmann, Berit Maria Pfitzner

Radiol Case Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms.
Maren Schmiester, Anna Dolnik, Uwe Kornak, Berit Pfitzner, Michael Hummel

J Pathol Clin Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP-1 expression as a prognostic factor in Desmoid-type fibromatosis.
Konstantin Bräutigam, Judith Lindner, Jan Budczies, Stefan Pahl, Annegret Kunitz, Berit Pfitzner

Ann Diagn Pathol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy with Olaratumab/doxorubicin in advanced or metastatic soft tissue sarcoma -a single-Centre experience.
Jana Käthe Striefler, Franziska Brandes, Alexander Baur, Berit Maria Pfitzner, David Kaul

BMC Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioactive coating of zirconia toughened alumina ceramic implants improves cancellous osseointegration.
Anne-Marie Pobloth, Max J Mersiowsky, Luisa Kliemt, Hanna Schell, Anke Dienelt, Berit M Pfitzner

Sci Rep· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII + IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trial.
Carsten Denkert, Jan Budczies, Meredith M Regan, Sibylle Loibl, Patrizia Dell'Orto, Berit M Pfitzner

Breast Cancer Res Treat· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer.
Philipp Jurmeister, Anne Schöler, Alexander Arnold, Frederick Klauschen, Dido Lenze, Berit Maria Pfitzner

Mod Pathol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular Predictor.
Sibylle Loibl, Karsten Weber, Jens Huober, Kristin Krappmann, Frederik Marmé, Berit Maria Pfitzner

Clin Cancer Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance and concordance of HER2 status in local and central testing-an analysis of 1581 HER2-positive breast carcinomas over 12 years.
Berit M Pfitzner, Bianca Lederer, Judith Lindner, Christine Solbach, Knut Engels

Mod Pathol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
Carsten Denkert, Gunter von Minckwitz, Silvia Darb-Esfahani, Bianca Lederer, Barbara I Heppner, Berit M Pfitzner

Lancet Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo effects of bupivacaine and gadobutrol on the intervertebral disc following discoblock and discography: a histological analysis.
Patrick Strube, Berit M Pfitzner, Florian Streitparth, Tony Hartwig, Michael Putzier

Eur Radiol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer.
Barbara Ingold Heppner, Michael Untch, Carsten Denkert, Berit M Pfitzner, Bianca Lederer

Clin Cancer Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Analysis of PTEN and p4EBP1 Protein Expression as Predictors for pCR in HER2-Positive Breast Cancer.
Sibylle Loibl, Silvia Darb-Esfahani, Jens Huober, Alexander Klimowicz, Jenny Furlanetto, Berit Pfitzner

Clin Cancer Res· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glutamate enrichment as new diagnostic opportunity in breast cancer.
Jan Budczies, Berit M Pfitzner, Balazs Györffy, Klaus-Jürgen Winzer, Cornelia Radke

Int J Cancer· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers.
Carsten Denkert, Gunter von Minckwitz, Jan C Brase, Bruno V Sinn, Stephan Gade, Berit M Pfitzner

J Clin Oncol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer.
Sibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, Stefan Paepke, Annika Lehmann, Berit Pfitzner

J Clin Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preanalytical variables and performance of diagnostic RNA-based gene expression analysis in breast cancer.
Christopher Poremba, Jennifer Uhlendorff, Berit M Pfitzner, Guido Hennig, Kerstin Bohmann

Virchows Arch· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patients.
Irène Baccelli, Albrecht Stenzinger, Vanessa Vogel, Berit Maria Pfitzner, Corinna Klein

Oncotarget· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes.
Silvia Darb-Esfahani, Gunter von Minckwitz, Carsten Denkert, Beyhan Ataseven, Bernhard Högel, Berit Pfitzner

BMC Cancer· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RANK expression as a prognostic and predictive marker in breast cancer.
Berit Maria Pfitzner, Daniel Branstetter, Sibylle Loibl, Carsten Denkert, Bianca Lederer

Breast Cancer Res Treat· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis